Sick of corporate greed

The scandal of expensive medicines

In spite of advances in medical innovation, millions of people around the world suffer and die from treatable conditions because medicines are too expensive.
Historically this has tragically affected low and middle-income countries. But in recent years, the NHS has also struggled to pay extortionate prices and has had to turn down or ration new medicines. 
 

Corporate profits trump public health

Why are medicines so expensive? Drug companies can charge runaway prices because new drugs are protected by legal monopolies. This profit-driven model has made the pharmaceutical industry the most profitable in the world. Drug companies justify high prices by claiming they need to recoup their research and development costs. But nine of the top ten pharmaceutical companies spend more on marketing than on research and development. Also, most early-stage innovative research is publically funded. Drug companies often buy up taxpayer funded research and reap the profits from charging extortionate prices while patients are denied access to vital medicines.

Join the fight for affordable medicines

We’ve joined forces with Missing Medicines – a coalition of UK organisations fighting for affordable medicines globally. We want conditions on all public health research to make sure the medicines developed are affordable and accessible here in the UK and across the world.

Latest Blog Posts

Are Big Pharma holding patients to ransom to boost their profits?


23 June 2017

The NHS has been forced into yet another secretive deal with a big pharmaceutical company to ensure access for cancer patients to the newest medicines. But while access to new drugs is obviously good news for cancer patients, the deal itself paints a bleak picture for the future of our NHS.

Why we can’t trust billionaires with our health


25 October 2017

Morten Thaysen introduces our new campaign against the corporate control of medicine.